Inactive Instrument

Human Genome Sciences Stock

Stocks

End-of-day quote Nasdaq
- ^USD	-

27/07/12	Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources	RE
16/07/12	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE

27/07/12	Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources	RE
16/07/12	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE
16/07/12	GlaxoSmithKline plc : Exclusive: GSK set for Human Genome takeover - sources	RE
15/07/12	GlaxoSmithKline plc : GSK in weekend talks to buy Human Genome: sources	RE
03/07/12	GlaxoSmithKline plc : GSK lines up nominees for Human Genome board	RE
29/06/12	GlaxoSmithKline plc : GSK further extends $2.6 billion Human Genome offer	RE
08/06/12	GlaxoSmithKline plc : GSK extends its $2.6 billion offer for Human Genome	RE
01/06/12	GlaxoSmithKline plc : Court denies request to curb Human Genome takeover defense	RE
31/05/12	Genmab A/S : Exclusive: GlaxoSmithKline eyes replacing Human Genome board	RE
30/05/12	GlaxoSmithKline plc : Exclusive: GSK eyes replacing Human Genome board	RE
23/05/12	GlaxoSmithKline plc : GSK to drop Human Genome bid if "poison pill" stands	RE
09/05/12	SANOFI : GSK goes hostile with $2.6 billion Human Genome offer	RE
02/05/12	Ardea Biosciences, Inc. : Biotech targets fight back as Big Pharma circles	RE

04/08/12	Human Genome Sciences : ANNOUNCES REQUIRED OFFER TO REPURCHASE IN RESPECT OF ITS 3.00% CONVERTIBLE SENIOR NOTES DUE 2018	PU
26/07/12	Human Genome Sciences : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Human Genome Sciences, Inc.	PR
20/07/12	Human Genome Sciences : Law Offices of Howard G. Smith Announces Investigation of Human Genome Sciences Inc. Board of Directors for Potential Breaches of Fiduciary Duty	BU
18/07/12	Human Genome Sciences : Law Office of Brodsky & Smith, LLC Announces Investigation of Human Genome Sciences, Inc.	PR
17/07/12	Human Genome Sciences : Ryan & Maniskas, LLP Announces Investigation of Human Genome Sciences Inc.	BU

25/07/12	GlaxoSmithKline plc : GlaxoSmithKline-T2 inférieur aux attentes, baisse du titre
16/07/12	GSK rachète Human Genome pour 3,0 milliards de dollars
16/07/12	GSK annonce le rachat de Human Genome pour $3,0 milliards
16/07/12	Human Genome : grimpe avec la nouvelle offre de GSK.
16/07/12	Wall Street ouvre en léger recul, mais Citi monte

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	-0.94%	-1.91%	+0.98%	+17.94%	50.47B
REVOLUTION MEDICINES, INC.	-2.22%	-3.59%	+416.01%	+500.47%	44.56B
IQVIA HOLDINGS INC.	-1.12%	-1.20%	+39.93%	+15.49%	43.08B
BEONE MEDICINES AG	-2.91%	-4.66%	+6.80%	+70.86%	41.7B
CELLTRION, INC.	-0.31%	-0.83%	+19.47%	+48.24%	33.21B
MEDPACE HOLDINGS, INC.	-1.51%	-5.29%	+24.06%	+117.28%	16.77B
ASCENDIS PHARMA A/S	+7.22%	+5.97%	-	-	16.28B
EUROFINS SCIENTIFIC SE	-0.30%	-1.53%	+11.02%	+26.92%	14.58B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.99%	-3.74%	+78.23%	+38.96%	13.92B
Average	-0.35%	-1.39%	+74.56%	+104.52%	30.51B
Weighted average by Cap.	-0.93%	-1.21%	+88.62%	+121.30%

Employees

Sector